1. Home
  2. CPHI

as of 12-12-2025 3:40pm EST

$1.66
+$0.16
+10.84%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Chart Type:
Time Range:
Founded: N/A Country:
China
China
Employees: N/A City: HAINAN PROVINCE
Market Cap: 8.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 39.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.00 EPS Growth: N/A
52 Week Low/High: $1.20 - $3.35 Next Earning Date: 11-12-2025
Revenue: $4,052,266 Revenue Growth: -26.91%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered CPHI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 57.69%
57.69%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: